168 related articles for article (PubMed ID: 34719353)
1. A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally.
Durocher J; Kilfedder C; Frye LJ; Winikoff B; Srinivasan K
Sex Reprod Health Matters; 2021 Dec; 29(1):1982460. PubMed ID: 34719353
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries.
Frye LJ; Kilfedder C; Blum J; Winikoff B
Contraception; 2020 May; 101(5):315-320. PubMed ID: 32032639
[TBL] [Abstract][Full Text] [Related]
3. Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities.
Grossman A; Prata N; Williams N; Ganatra B; Lavelanet A; Läser L; Asmani C; Elamin H; Ouedraogo L; Rahman MM; Conneh-Duworko MJ; Tehoungue BZ; Chanza H; Phiri H; Bhattarai B; Dhakal NP; Ojo OA; Afolabi K; Kabuteni TJ; Hailu BG; Moses F; Dlamini-Nqeketo S; Zulu T; Rehnström Loi U
Reprod Health; 2023 Apr; 20(Suppl 1):58. PubMed ID: 37041543
[TBL] [Abstract][Full Text] [Related]
4. Quality testing of mifepristone and misoprostol in 11 countries.
Bower J; Chinery L; Fleurent A; Gülmezoglu AM; Im-Amornphong W; Kilfedder C; Procter P; Tomazzini A
Int J Gynaecol Obstet; 2024 May; 165(2):405-415. PubMed ID: 37775986
[TBL] [Abstract][Full Text] [Related]
5. In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments.
Rehnström Loi U; Prata N; Grossman A; Lavelanet A; Williams N; Ganatra B
Reprod Health; 2023 Jan; 20(Suppl 1):20. PubMed ID: 36694182
[TBL] [Abstract][Full Text] [Related]
6. Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.
Chinery L; Allaouidine C; Tomazzini A; Larson M; Gülmezoglu AM
Reprod Health; 2020 Nov; 17(1):171. PubMed ID: 33148282
[TBL] [Abstract][Full Text] [Related]
7. Exploring the feasibility of obtaining mifepristone and misoprostol from the internet.
Murtagh C; Wells E; Raymond EG; Coeytaux F; Winikoff B
Contraception; 2018 Apr; 97(4):287-291. PubMed ID: 29030227
[TBL] [Abstract][Full Text] [Related]
8. Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
Afifi M; Hemachandra N; Sikandar Q; Hajjeh R; Loi UR; Läser L; Qato D; Abdul ZS; Chikvaidze P; Abbas RAR; Al-Kinani K; Hasan H; El-Kak F; Rady A; Brngali O; Hashem M; Bezad R; Amine C; Hafid H; Afzal S; Zaidi R; Thom E; Uzma Q; Al-Masri H; Qamar ZA; Ghanem B; Ward IA; Shaar AN; Farah U; Mohamed YO; Umar AU; Eladawy M
Reprod Health; 2024 Jun; 20(Suppl 1):192. PubMed ID: 38835050
[TBL] [Abstract][Full Text] [Related]
9. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
Ngoc NT; Blum J; Raghavan S; Nga NT; Dabash R; Diop A; Winikoff B
Contraception; 2011 May; 83(5):410-7. PubMed ID: 21477682
[TBL] [Abstract][Full Text] [Related]
10. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
[TBL] [Abstract][Full Text] [Related]
11. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
[TBL] [Abstract][Full Text] [Related]
12. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
Guengant JP; Bangou J; Elul B; Ellertson C
Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
Ferguson I; Scott H
J Obstet Gynaecol Can; 2020 Dec; 42(12):1532-1542.e2. PubMed ID: 32912726
[TBL] [Abstract][Full Text] [Related]
14. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion.
Tamang A; Puri M; Lama K; Shrestha P
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):104-15. PubMed ID: 25702074
[TBL] [Abstract][Full Text] [Related]
15. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
16. Landscape assessment of the availability of medical abortion medicines in India.
Karna P; Sharma KA; Grossman A; Gupta M; Chatterjee T; Williams N; Prata N; Sorhaindo A; Läser L; Rehnström Loi U; Ganatra B; Chaudhary P
Reprod Health; 2024 Jun; 20(Suppl 1):193. PubMed ID: 38840263
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia.
Murthy A; Creinin MD
Expert Opin Pharmacother; 2003 Apr; 4(4):503-13. PubMed ID: 12667113
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
19. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
Creinin MD; Shore E; Balasubramanian S; Harwood B
Contraception; 2005 Jan; 71(1):26-30. PubMed ID: 15639068
[TBL] [Abstract][Full Text] [Related]
20. Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States.
Johnson DM; Ramaswamy S; Gomperts R
Contraception; 2024 Mar; 131():110345. PubMed ID: 38049047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]